Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Pharmacotherapy. 2012 Aug;32(8):772–780. doi: 10.1002/j.1875-9114.2012.01103.x

Table 1.

Descriptive statistics of variables at baseline

Control group Intervention group P-Value

N = 244 N = 252
Sex 0.32
 Female 57.4% 61.9%
 Male 42.6% 38.1%
Race/ethnicity
 White/Hispanic 85.7% 89.7% 0.22
 African American 10.7% 3.6% 0.003
 Others 3.7% 6.8% 0.16
Average age in years (SD) 61.3 (12.9) 59.1 (13.7) 0.06
Married/living as married 54.9% 64.7% 0.03
Smoking status
 Never smoked 44.7% 52.0% 0.11
 Current smokers 22.5% 16.3% 0.09
 Ex-smokers 32.8% 31.8% 0.85
Alcohol intake >0.99
 None or less than 1 drink per day 86.2% 86.1%
 One or more drink(s) per day 13.8% 13.9%
Average number of anti-hypertensive agents (SD) at baseline 1.7 (1.0) 1.3 (1.0) <0.001
Average number of co-existing chronic conditions 0.6 (0.9) 0.4 (0.7) <0.001
Average baseline systolic blood pressure in mm Hg (SD) 150.8 (12.7) 153.5 (11.8) 0.01
Average baseline diastolic blood pressure mm Hg (SD) 83.1 (11.9) 86.4 (11.7) 0.002
a

Co-existing conditions included diabetes mellitus, peripheral artery disease, left ventricular hypertrophy, coronary artery bypass surgery, stroke, chronic kidney disease, heart failure, angina, and myocardial infarction.